$ #novo nordisk novo nordisk (buy, tp: dkk410.00) - tresiba granted label extension | today the fda granted a label extension for tresiba, based on the devote study, which demonstrated significantly lower hypoglycaemia events versus... https://t.co/y0nd8eylcn #markets #equity https://t.co/yrt1jpolzl